https://www.selleckchem.com/pr....oducts/gsk923295.htm
Importantly, the data from in vivo experiment revealed that DOX/NPs without heart toxicity significantly inhibited tumor metastasis by exerting synergistic therapeutic effect, and reduced tumor volume and weight by inducing apoptosis. The nanocarrier DOX/NPs with satisfying pharmaceutical characteristics based on the establishment of two different functional agents is a promising strategy for synergistically enhancing effects of cancer therapy. The nanocarrier DOX/NPs with satisfying pharmaceutical characteristics based on the establi
Aimer
Commentaire
Partagez
